PDX1 and diabetes mellitus: PDX1 heterozygous mutations are associated with insulin secretion deficiency. Common point heterozygous mutations in the PDX1 transactivation domain impair human pancreatic β cell formation and function, and contribute to increased risk for diabetes. Pancreatic developmental anomalies related to PDX1 mutations are reported only in neonatal diabetes cases.